0000921895-23-002396.txt : 20231026
0000921895-23-002396.hdr.sgml : 20231026
20231026163307
ACCESSION NUMBER: 0000921895-23-002396
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231025
FILED AS OF DATE: 20231026
DATE AS OF CHANGE: 20231026
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NATAN DAVID
CENTRAL INDEX KEY: 0001253108
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 231350593
MAIL ADDRESS:
STREET 1: 11190 BISCAYNE BLVD
CITY: MIAMI
STATE: FL
ZIP: 33181
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form413531002nat_10262023.xml
OWNERSHIP DOCUMENT
X0508
4
2023-10-25
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP
0001253108
NATAN DAVID
11190 BISCAYNE BLVD
MIAMI
FL
33181
1
0
0
0
0
Common Stock
2023-10-25
4
A
0
16250
0
A
66250
D
The shares reported in this transaction represent Unrestricted Stock Awards pursuant to the Issuer's Fourth Amended and Restated 2015 Omnibus Equity Incentive Plan that vested immediately on the date of grant.
/s/ David Natan
2023-10-26